Breaking News

Oxford Expands Biomanufacturing Real Estate Platform with Purchase, Lease Back of GMP Facility

Acquisition expands Oxford's North American cGMP real estate portfolio and pipeline to 2.4 million square feet across 12 sites.

Oxford Properties Group, a global real estate investor, asset manager and business builder, announced the purchase and long-term lease back of 92 Crowley Drive. The asset is a 120,000 square foot state-of-the-art biomanufacturing facility under construction in the Boston life sciences submarket of Marlborough, MA. As part of a real estate transaction with Resilience, a technology-focused biomanufacturing company, Oxford will acquire the building and lease the property back to Resilience fo...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters